Filing Flows › GeoVax Labs (GOVX) › Q1 2025
GeoVax Labs (GOVX) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 1, 2025
GeoVax Labs (GOVX) reported revenue of $1.6M for the first quarter 2025 (Q1 2025) and +89% from the quarter before. Operating margin was -330.2%, net loss $5.4M (327.3% of revenue).
GeoVax Labs, Q1 2025: revenue $1.6M, operating margin -330.2%, net loss $5.4M, operating cash flow −$6.0M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.6M | +89% | — |
| Operating profit | −$5.4M | — | — |
| Net earnings | −$5.4M | — | — |
| Operating cash flow | −$6.0M | — | — |
What changed
Revenue was $1.6M in Q1 2025, up 89% from the previous quarter.
Operating costs exceeded revenue by $5.4M, an operating margin of -330.2%. The quarter ended with a net loss of $5.4M, narrower than the previous quarter's $8.3M loss.
Operating cash flow was −$6.0M. Non-cash charges added back $17K of depreciation and amortization and $293K of share-based compensation. Working capital and other items used $918K. Capital expenditures of $17K exceeded it, leaving free cash flow of −$6.0M.
Questions
What was GeoVax Labs' revenue in the first quarter 2025?
GeoVax Labs (GOVX) reported revenue of $1.6M for the first quarter 2025 (Q1 2025) and +89% from the quarter before.
Was GeoVax Labs profitable in the first quarter 2025?
Operating loss was $5.4M (-330.2% of revenue) and net loss $5.4M.
Source: GeoVax Labs 10-Q on SEC EDGAR.